How many insider trades does FilingIQ track for NUVB?

FilingIQ tracks 125 Form 4 insider transactions for NUVB (Nuvation Bio Inc.), covering filings from Feb 12, 2021 onwards. 4 of those are dated within the last 90 days.

Are NUVB insiders net buyers or net sellers?

Across the full Form 4 history for NUVB, 40 transactions (32%) were open-market purchases and 29 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NUVB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is NUVB in?

Nuvation Bio Inc. (NUVB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

NUVB insider trading

NYSE Healthcare

Nuvation Bio Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

125

Last 90 days

Buys / sells

32% / 23%

Market cap

$1.49B

About Nuvation Bio Inc.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.

Company website: www.nuvationbio.com

NUVB insider activity at a glance

FilingIQ tracks 125 insider transactions for NUVB in filings since Feb 12, 2021. The most recent transaction is dated Aug 19, 2026.

Across the full history, 40 open-market purchases and 29 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NUVB insider trades is 57.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NUVB trades on FilingIQ Raw filings on SEC EDGAR

Latest NUVB Form 4 filings

Hattersley Gary CHIEF SCIENTIFIC OFFICER

SM Aug 21, 2026

Sauvage Philippe Chief Financial Officer

M Jul 17, 2026

Sauvage Philippe Chief Financial Officer

SM Jun 24, 2026

Markel Stacy CHIEF PEOPLE OFFICER

SM Jun 24, 2026

Wentworth Kerry CHIEF REGULATORY OFFICER

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Top insiders trading NUVB

Sauvage Philippe

6 trades · score 70.5

Frequently asked

How many insider trades does FilingIQ track for NUVB?: FilingIQ tracks 125 Form 4 insider transactions for NUVB (Nuvation Bio Inc.), covering filings from Feb 12, 2021 onwards. 4 of those are dated within the last 90 days.
Are NUVB insiders net buyers or net sellers?: Across the full Form 4 history for NUVB, 40 transactions (32%) were open-market purchases and 29 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NUVB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is NUVB in?: Nuvation Bio Inc. (NUVB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

Methodology & sources

Every NUVB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.